Neural effects of imagined placebo intake

Neural effects of imagined placebo intake - Imagery and OLP

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00030353

Enrollment

100

Registered

2022-10-05

Start date

2022-10-28

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy participants

Interventions

Group 1: Viewing of images (digsting, neutral) after taking a placebo pill (with dextrose) Group 2: Viewing of images (digusting, neutral) after imagining taking a placebo pill (with dextrose) Group 3

Eligibility

Sex/Gender

Female

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: female sex; age >= 18 years

Exclusion criteria

Exclusion criteria: self-reported diagnoses of mental illnesses, neurological disorders, intake of psychotropic medication, contraindications for MRI scanning (e.g. pregnancy, metal implants).

Design outcomes

Primary

Measure	Time frame
Disgust ratings for teh images (1 = not disgusting; 9 = very disgusting)	—

Secondary

Measure	Time frame
activity: insula, amygdala, and cognitive control regions (e.g., DLPFC, OFC)	—

Countries

Austria

Contacts

Public ContactAnne Schienle

Universität Graz

anne.schienle@uni-graz.at+43 316 380-5086

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026